PLC δ 4 Antibodies

Santa Cruz Biotechnology delivers a wide array of PLC δ 4 monoclonal antibodies for research focused on understanding phospholipase C delta 4. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phospholipase C delta 4 (PLC δ 4) is a key enzyme involved in the phosphoinositide signaling pathway, playing a crucial role in cellular processes such as proliferation, differentiation, and apoptosis. Its activity is essential for the regulation of intracellular calcium levels and the generation of second messengers, which are vital for various physiological responses. Understanding PLC δ 4 function is important for elucidating its involvement in diseases, including cancer and neurodegenerative disorders. Researchers can explore molecular mechanisms and signaling pathways with reliable detection methods using specific monoclonal antibodies. Advanced research techniques supported by PLC δ 4 monoclonal antibodies enable investigation of cellular functions and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for PLC δ 4 support scientific advancement by facilitating precise and reproducible research outcomes in the scientific community.